The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis ; volume:17 ; number:1 ; day:5 ; month:1 ; year:2017 ; pages:1-11 ; date:12.2017
Cancer cell international ; 17, Heft 1 (5.1.2017), 1-11, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Lin, Jiaying
- Contributor
-
Ding, Ding
SpringerLink (Online service)
- DOI
-
10.1186/s12935-016-0376-4
- URN
-
urn:nbn:de:1111-20170222666
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Jiaying
- Ding, Ding
- SpringerLink (Online service)
Other Objects (12)
The prognostic value and immunological role of CD44 in pan-cancer study
Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
The prognostic value of the Hedgehog signaling pathway in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
The Prognostic Value of PARP Expression in High-Grade Epithelial Ovarian Cancer
The prognostic value and immunological role of CD44 in pan-cancer study
Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
The prognostic value of the Hedgehog signaling pathway in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
The Prognostic Value of PARP Expression in High-Grade Epithelial Ovarian Cancer
The prognostic value and immunological role of CD44 in pan-cancer study
Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
The prognostic value of the Hedgehog signaling pathway in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study